Dr. Henning A. Gaissert

About Henning A. Gaissert

Accolades

• 

  Board Certified in Thoracic Surgery

• 

  Pleural and Lung Cancer

• 

  Team Leader

Get to Know Dr. Henning A. Gaissert

Dr. Henning A. Gaissert oversees the thoracic surgery department at Newton-Wellesley Hospital. This department handles the treatment of chest tumors with a multidisciplinary approach that includes oncologists, pathologists, radiologists and surgeons. Newton-Wellesley’s thoracic surgery team treats esophageal and lung cancers.

Gaissert also plays a prominent role in the acclaimed thoracic surgery program at Massachusetts General Hospital. He has experience with a variety of thoracic diseases, including lung cancer and pleural mesothelioma.

The Center for Thoracic Cancers at Massachusetts General Hospital was one of the first in the country to use novel targeted therapies for certain types of chest cancer. Its innovative approach to clinical care includes one of New England’s only proton therapy facilities.

Before coming to Massachusetts General Hospital and Newton-Wellesley, Gaissert led the thoracic surgery team at Rhode Island Hospital and Brown University. He served his fellowship and residency in surgery at Massachusetts General Hospital and Barnes-Jewish Hospital in St. Louis.

Gaissert received his medical degree from the Technical University of Munich Faculty of Medicine. He was born and raised in Hamburg, Germany.

Specialties of Dr. Henning A. Gaissert

• Pleural mesothelioma

• Lung cancer

• Thoracic surgery

• Multimodal therapy

Dr. Henning A. Gaissert Experience and Medical Education

• Technical University of Munich Faculty of Medicine (Medical school)

• Barnes-Jewish Hospital, Massachusetts General Hospital (Fellowship and residency)

Awards and Certifications

• Top Doctor, Castle Connolly, 2007-2020

• Top Doctor for Cancer, Castle Connolly, 2006-2020

• Top Doctor, Boston Magazine, 2008-2020

• Top Doctor, Newsweek, 2015

• Board certified in thoracic surgery

See More Top Mesothelioma Doctors

Publications of Dr. Henning A. Gaissert

• Udelsman, B.V. et al. (2020, August). Concordance of Clinical and Pathological Nodal Staging in Resectable Lung Cancer. Annals of Thoracic Surgery.

• Best, T.D. et al. (2020, July). Multilevel Body Composition Analysis on Chest Computed Tomography Predicts Hospital Length of Stay and Complications After Lobectomy for Lung Cancer: A Multicenter Study. Annals of Surgery.

• Madariaga, M.L. & Gaissert, H.A. (2020). The many benefits of a multidisciplinary evaluation of lung nodules. Journal of Cardiovascular Surgery.

Top